The interface of Hodgkin's disease and anaplastic large cell lymphoma

Cancer Surveys

Volumn 30, Issue , 1997, Pages 87-105

  Chittal, S M ^a,b   Delsol, G ^a,b  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN ANTIBODY COMPLEX; CANCER GRADING; CANCER LOCALIZATION; CANCER STAGING; CELL PROLIFERATION; DISEASE ASSOCIATION; GENOTYPE; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

HODGKIN DISEASE; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, LARGE-CELL, ANAPLASTIC; LYMPHOMA, LARGE-CELL, KI-1;

EID: 0030880682     PISSN: 02612429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (103)

1. Agnarsson B and Kadin M (1988) Ki-1 positive large cell lymphoma: a morphologic and immunologic study of 19 cases. American Journal of Surgical Pathology 12 264-274
2. Al Saati T, Tkaczuk J, Krissansen G et al. (1995) A novel antigen detected by the CBF78 antibody further distinguishes anaplastic large cell lymphoma from Hodgkin's disease. Blood 86 2741-2746
3. Armitage JO (1993) Treatment of non-Hodgkin's lymphoma. New England Journal of Medicine 328 1023-1030
4. Beljaards RC, Kaudewitz P, Berti E et al. (1993) Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European multicenter study. Cancer 71 2097-2104
5. Bitter MA, Franklin WA, Larson RA et al. (1990) Morphology in Ki-1 (CD30)-positive non- Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). American Journal of Surgical Pathology 14 305-316
6. Brousset P, Chittal S, Schlaifer D et al. (1991) Detection of Epstein-Barr virus messenger RNA in Reed-Sternberg cells of Hodgkin's disease by in situ hybridisation with biotinylated probes on specially processed modified acetone methyl benzoate xylene (ModAMeX) sections. Blood 77 1781-1786
7. Brousset P, Rochaix P, Chittal S, Rubie H, Robert A and Delsol G (1993a) High incidence of Epstein-Barr virus detection in Hodgkin's disease and absence of detection in anaplastic large cell lymphoma in children. Histopathology 23 189-191
8. Brousset P, Meggetto F, Chittal S et al. (1993b) Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease. Laboratory Investigation 69 483-490
9. Butler JJ (1992) The histologic diagnosis of Hodgkin's disease. Seminars in Diagnostic Pathology 9 252-256
10. Cabanillas F, Pathak S, Trujillo J et al. (1988) Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyte. Blood 71 1615-1617
11. Carbone A, Gloghini A and Volpe R (1992a) Paraffin section immunohistochemistry in the diagnosis of Hodgkin's disease and anaplastic large cell (CD30+) lymphomas. Virchows Archiv A Pathological Anatomy and Histopathology 420 527-532
12. Carbone A, Gloghini A and Volpe R (1992b) Immunohistochemistry of Hodgkin and non- Hodgkin lymphomas with emphasis on the diagnostic significance of the BNH9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas. Cancer 70 2691-2698
13. Chan JKC, Ng CS, Hui P-K et al. (1989) Anaplastic large cell Ki-1 lymphoma: delineation of two morphological types. Histopathology 15 11-34
14. Chan JKC, Buchanan R and Fletcher CDM (1990) Sarcomatoid variant of anaplastic large cell Ki-1 lymphoma. American Journal of Surgical Pathology 14 983-988
15. Chittal SM, Alard C, Rossi J-F et al. (1990) Further phenotypic evidence that nodular lymphocyte predominance Hodgkin's disease is a large B-cell lymphoma in evolution. American Journal of Surgical Pathology 14 1024-1035
16. Chittal SM, Brousset P, Voigt JJ and Delsol G (1991) Large B-cell lymphoma rich in T-cells and simulating Hodgkin's disease. Histopathology 19 211-220
17. Chittal SM, Caverviere P, Schwarting R et al. (1988) Monoclonal antibodies in the diagnosis of Hodgkin's disease: the search for a rational panel. American Journal of Surgical Pathology 12 9-21
18. Chott A, Kaserer K, Augustin I et al. (1990) Ki-1 positive large cell lymphoma: a clinicopathologic study of 41 cases. American Journal of Surgical Pathology 14 439-448
19. de Bruin PC, Beljaards RC, van Heerde P et al. (1993) Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell (CD30+) lymphomas of T-cell or null cell phenotype. Histopathology 23 127-135
20. DeCoteau JF, Butmarc JR, Kinney MC and Kadin ME (1996) The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. Blood 87 3437- 3441
21. Delsol G, Gatter KC, Stein H et al. (1984) Human lymphoid cells express epithelial membrane antigen. Implications for the diagnosis of human neoplasms. Lancet ii 1124-1128
22. Delsol G, AI Saati T, Gatter K et al. (1988) Co-expression of epithelial membrane antigen (EMA), Ki-1 and interleukin-2 receptor by anaplastic large cell lymphomas: diagnostic value in so-called malignant histiocytosis. American Journal of Pathology 130 59-70
23. Delsol G, Blancher A, Al Saati T et al. (1991) Antibody BNH9 detects red blood cell-antigens on anaplastic large cell (CD30+) lymphomas. British Journal of Cancer 64 321-326
24. Delsol G, Brousset P, Chittal S and Rigal-Huguet F (1992) Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamHI-W probes in Hodgkin's disease. American Journal of Pathology 140 247-253
25. Delsol G, Meggetto F, Brousset P et al. (1993) Relation of follicular dendritic reticulum cells to Reed-Sternberg cells of Hodgkin's disease with emphasis on the expression of CD21 Antigen. American Journal of Pathology 142 1729-1738
26. Diehl V, von Kalle C, Fonatsch C, Tesch H, Juecker M and Schaadt M (1990) The cell of origin in Hodgkin's disease. Seminars in Oncology 17 660-672
27. Dorfman RF, Gatter KC, Pulford KAF and Mason DY (1986) An evaluation of antigranulocyte and anti-leukocyte monoclonal antibodies in the diagnosis of Hodgkin's disease. American Journal of Pathology 123 508-519
28. Downing J, Shurtleff S, Zielenska M et al. (1995) Molecular detection of the t(2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase polymerase chain reaction. Blood 85 3416-3422
29. Falini B, Pileri S, Stein H et al. (1990) Variable expression of leucocyte-common (CD45) antigen in CD30 (Ki-1)-positive anaplastic large cell lymphoma: implications for the differential diagnosis of lymphoid and nonlymphoid malignancies. Human Pathology 21 624-629
30. Falini B, Pileri S, Pizzolo G et al. (1995) CD30 (Ki-1) molecule: a new eytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 85 1-14
31. Filippa DA, Ladanyi M, Wollner N et al. (1996) CD30 (Ki-)-positive malignant lymphomas: clinical, immunophenotypic, histologic, and genetic characteristics and differences with Hodgkin's disease. Blood 87 2905-2917
32. Frierson HF, Bellafiore FJ, Gaffey MJ, McCary WF, Innes DJ and Williams ME (1994) Cytokeratin in anaplastic large cell lymphoma. Modern Pathology 7 317-321
33. Frizzera G (1992) The distinction of Hodgkin's disease from anaplastic large cell lymphoma. Seminars in Diagnostic Pathology 9 291-296
34. Fujimoto J, Hata J, Ishii E et al. (1988) Ki-1 lymphomas in childhood: immunohistochemical analysis and the significance of epithelial membrane antigen as a new marker. Virchows Archiv A Pathological Anatomy and Histopathology 412 307-314
35. Greer JP, Kinney MC, Collins RD et al. (1991) Clinical features of 31 patients with anaplastic large-cell lymphoma. Journal of Clinical Oncology 9 539-547
36. Gustmann C, Altmannsberger M, Osborn M, Griesser H and Feller AC (1991) Cytokeratin expression and vimentin content in large cell anaplastic lymphomas and other non-Hodgkin's lymphomas. American Journal of Pathology 138 1413-1422
37. Hall PA, D'Ardenne AJ and Stansfeld AG (1988) Paraffin section immunohistochemistry II: Hodgkin's disease and large-cell anaplastic (Ki-1) lymphoma. Histopathology 13 161-169
38. Haluska FG, Brufsky AM and Canellos GP (1994) The cellular biology of the Reed-Sternberg cell. Blood 84 1005-1019
39. Harris NL, Jaffe ES, Stein II et al. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 84 1361-1392
40. Herbst H, Tippelman G, Anagnostopoulos I et al. (1989) Immunoglobulin and T cell receptor gene rearrangements in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma: dissociation between phenotype and genotype. Leukemia Research 13 103-116
41. Herbst H, Stein H and Niedobitek G (1993) Epstein-Barr virus and GD30+ malignant lymphomas. Critical Reviews in Oncogenesis 4 191-239
42. Hess JL, Bodis S, Pinkus G, Silver B and Mauch P (1994) Histologic grading of nodular sclerosis Hodgkin's disease. Lack of prognostic significance in 254 surgically staged patients. Cancer 74 704-718
43. Hsu S-M and Hsu P-L (1994) The nature of Reed-Sternberg cells: phenotype, genotype and other properties. Critical Reviews in Oncogenesis 5 213-245
44. Hugh J and Poppema S (1992) Immunophenotype of Reed-Sternberg cells. International Review of Experimental Pathology 33 81-114
45. Hummel H, Ziemann K, Lammert H, Pileri S, Sabattini E and Stein H (1995) Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells. New England Journal of Medicine 333 901-906
46. Jack AS, Cunningham D, Soukop M, Liddle CN and LeeFD (1986) Use of Leu-M1 and antiepithelial membrane antigen monoclonal antibodies for diagnosing Hodgkin's disease. Journal of Clinical Pathology 39 267-270
47. Jones DB, Gerdes J, Stein H and Wright DH (1986) An investigation of Ki-1 positive large cell lymphoma with antibodies reactive with tissue macrophages. Hematological Oncology 4 315-22
48. Kadin ME (1994) Primary Ki-1-positive anaplastic large cell lymphoma: a distinct clinicopathologic entity. Annals of Oncology 5 (Supplement 1) S25-S30
49. Kaudewitz P, Stein H, Dallenbach F et al. (1989) Primary and secondary cutaneous Ki-l+ (CD30+) anaplastic large cell lymphomas: morphologic, immunohistologic and clinical characteristics. American Journal of Pathology 135 359-367
50. Kinney MC, Collins RD, Greer JP, Whitlock JA, Sioutos N and Kadin ME (1993) A small cell predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma. American Journal of Surgical Pathology 17 859-868
51. Korkolopolou P, Cordell J, Jones M et al. (1994) The expression of the B-cell marker mb-1 (CD79a) in Hodgkin's disease. Histopathology 24 511-515
52. Kuzu I, Delsol G, Jones M, Gatter KC and Mason DY (1993) Expression of the Ig-associated heterodimer (mb-1 and B-29) in Hodgkin's disease. Histopathology 22 141-144
53. Ladanyi M, Cavalchire G, Morris SM, Downing J and Filipa DA (1994) Reverse transcriptase polymerase chain reaction for the Ki-1 anaplastic large cell lymphoma-associated t(2;5) translocation in Hodgkin's disease. American Journal of Pathology 145 1296-1300
54. Lamant L, Meggetto F, Al Saati T et al. (1996) High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease: comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-8O immunostaining. Blood 87 284-291
55. LeBeau MM, Bitter MA, Larson RA et al. (1989) The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. Leukemia 3 866-870
56. Leoncini L, Del Vecchio MT, Kraft R et al. (1990) Hodgkin's disease and CD30-positive anaplastic large cell lymphomas - a continuous spectrum of malignant disorders: a quantitative morphometric and immunologic study. American Journal of Pathology 137 1047-1057
57. Lopatgui JR, Gaffey MJ, Chan JK et al. (1995) Infrequent association of Epstein-Barr virus with CD-30 positive anaplastic large cell lymphomas from American and Asian patients. American journal of Surgical Pathology 19 42-49
58. Lukes RJ, Craver LF, Hall TC, Rappaport H and Ruben P (1966) Report of the nomenclature committee. Cancer Research 26 1311
59. McBride JA, Roderiguez J, Luthra R, Ordonez N, Cabanillas F and Pugh WC (1996) T-cell-rich B large-cell lymphoma simulating lymphocyte-rich Hodgkin's disease. American Journal of Surgical Pathology 20 193-201
60. Madeiros LJ, Weiss LM, Warake RA and Dorfman RF (1988) Utility of combining antigranulocyte with antileukocyte antibodies in differentiating Hodgkin's disease from non-Hodgkin's lymphomas. Cancer 62 2475-2481
61. Mann KP, Hall B, Kamino H, Borowitz MJ and Ratech H (1995) Neutrophil-rich, Ki-1-positive anaplastic large cell lymphoma. American Journal of Surgical Pathology 19 407-416
62. Masih AS, Weisenburger DD, Vose JM, Bast MA and Armitage JO (1992) Histologic grade does not predict prognosis in optimally treated advanced stage nodular sclerosis Hodgkin's disease. Cancer 69 228-232
63. Mason DY, Cordell JL, Brown M et al. (1989) Detection of T-cells in paraffin embedded tissue using antibodies against a peptide sequence from the CD3 antigen. Journal of Clinical Pathology 42 1194-1200
64. Mason D, Bastard C, Rimokh R et al. (1990a) CD30-positive large cell lymphomas ('Ki-1 lymphoma') are associated with a chromosomal translocation involving 5q35. British Journal of Haematology 74 161-168
65. Mason DY, Commans-Bitter WM, Cordell JL, Verhoeven MJ and van Dongen JJM (1990b) Antibody L26 recognizes an intracellular epitope on the B-cell associated CD20 antigen. American Journal of Pathology 136 1215-1222
66. Mason DY, Cordell JL, Tse AGD et al. (1991) The IgM associated protein mb-1 as a marker of normal and neoplastic B cells. Journal of Immunology 147 2474-2484
67. Mason DY, Banks PM, Chan J et al. (1994) Nodular lymphocyte predominance Hodgkin's disease: a distinct clinicopathological entity. American Journal of Surgical Pathology 18 526- 530
68. Meggetto F, Al Saati T, Rubin B and Delsol G (1994) Lack of restricted T-cell receptor β-chain variable region (Vβ) usage of reactive T-lymphocytes in Hodgkin's disease. British Journal of Haematology 86 524-532
69. Morris SW, Kirstein MN, Valentine MB et al. (1994) Fusion of kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263 1281-1284
70. Nakamura S, Takagi N, Kojima M et al. (1991) Clinicopathologic study of large cell anaplastic lymphoma (Ki-positive large cell lymphoma) among the Japanese. Cancer 68 118-129
71. Orscheschek K, Merz H, Hell J, Binder T, Bartels H and Feller AC (1995) Large-cell anaplastic lymphoma-specific translocation t(2;5)(p23;q35) in Hodgkin's disease: indications of a common pathogenesis? Lancet 345 87-90
72. Pallesen G and Hamilton-Dutoit SJ (1988) Ki-1 (CD30) antigen is regularly expressed by tumor cells of embryonal carcinoma. American Journal of Pathology 133 446-450
73. Penny RJ, Blaustein JC, Longtine JA and Pinkus GS (1991) Ki-1 positive large cell lymphomas, a heterogeneous group of neoplasms: morphologic, immunophenotypic, genotypic and clinical features of 24 cases. Cancer 68 362-373
74. Perkins PL, Ross CW and Schnitzer B (1992) CD30-positive, anaplastic large-cell lymphomas that express CD15 but lack CD45: a possible diagnostic pitfall. Archives of Pathology and Laboratory Medicine 116 1192-1196
75. Pileri S, Bocchia M, Baroni CD et al. (1994) Anaplastic large cell lymphoma (CD30+/Ki-1+): results of a prospective clinicopathologic study of 69 cases. British Journal of Haematology 86513-523
76. Pileri S, Falini B, Delsol G et al. (1990) Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1+) with a high content of reactive histiocytes. Histopathology 16 383-391
77. Pileri S, Piccaluga A, Poggi S et al. (1995) Anaplastic large cell lymphoma: update of findings. Leukemia and Lymphoma 18 17-25
78. Poppema S, Hollema H, Visser L et al. (1987) Monoclonal antibodies (MT-1, MT-2, MB-1, MB- 2, MB-3) reactive with leukocyte subsets in paraffin embedded tissue sections. American journal of Pathology 127 418-429
79. Pulford KAF, Rigney EM, Micklem KS et al. (1989) KP1-a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. journal of Clinical Pathology 42 414-421
80. Pulford K, Lamant L, Morris SW et al. (1997) Detection ALK and NPM-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood 89 1394-1404
81. Reiter A, Schrappe M, Tiemann M et al. (1994) Successful treatment strategy for Ki-1 anaplastic large cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. Journal of Clinical Oncology 12 899- 908
82. Rimokh R, Magaud J-P, Berger F et al. (1989) A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ('Ki-1 lymphoma'). British Journal of Haematology 71 31-36
83. Rosso R, Pauli M, Magrini U et al. (1990) Anaplastic large cell lymphoma, CD30/Ki-l positive, expressing the CD15/Leu Ml antigen: immimohistochemical and morphological relationships to Hodgkin's disease. Virchows Archiv A Pathological Anatomy and Histopathology 416 229-235
84. Sandlund JT, Pui C-H, Roberts WM et al. (1994) Clinicopathologic features and treatment outcome of children with large cell lymphoma and the t(2;5)(p23;q35). Blood 84 2467-2471
85. Sandlund JT, Downing JR and Crist WM (1996) Non-Hodgkin's lymphoma in childhood. New England journal of Medicine. 334 1238-1248
86. Schmid C, Pan L, Diss T and Isaacson PG (1991) Expression of B-cell antigens by Hodgkin's and Reed-Sternberg cells. American journal of Pathology 139 701-707
87. Schouten HC, Sauger WG, Duggan M, Weisenburger DD, MacLennan KA and Armitage JO (1988) Chromosomal abnormalities in Hodgkin's disease. Blood 73 2149-2154
88. Schwab U, Stein H, Gerdes J et al. (1982) Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 299 65-67
89. Schwarting R, Gerdes J, Durkop J, Falini B, Pileri S and Stein H (1989) Ber-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistent epitope. Blood 74 1678-1689
90. Shiota M, Fujimoto J, Takenaga M et al. (1994) Diagnosis of t(2;5)(p23;q 35)-associated Ki-1 lymphoma with immunohistochemistry. Blood 84 3648-3652
91. Shulman LN, Frisard B, Antin JH et al. (1993) Primary Ki-1 anaplastic large cell lymphoma in adults: clinical characteristics and therapeutic outcome, journal of Clinical Oncology 11 937-942
92. Stein H and Dallenbach F (1992) Diffuse large cell lymphomas of B- and T-cell types, In: Knowles DM (ed). Neoplastic Hematopathology, pp 675-715, Williams and Wilkins, Baltimore
93. Stein H, Hansmann M-L, Lennert K, Brandzaeg P, Gatter KC and Mason DY (1986) Reed- Sternberg and Hodgkin cells in lymphocyte predominant Hodgkin's disease of nodular subtype contain J-chain. American journal of clinical Pathology 86 292-297
94. Stein H, Mason D, Gerdes J et al. (1985) The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66 848-858
95. Strickler J, Michie S, Warnke R and Dorfman R (1986) The 'syncytial variant' of nodular sclerosing Hodgkin's disease. American Journal of Surgical Pathology 10 470-477
96. Tilly H, Bastard C, Delastre T et al. (1991) Cytogenetic features in untreated Hodgkin's disease. Blood 77 1298-1304
97. Urba WJ and Longo DL (1992) Hodgkin's disease. New England Journal of Medicine 326 678- 687
98. Weiss LM and Chang KL (1992) Molecular biologic studies of Hodgkin's disease Seminars in Diagnostic Pathology 9 272-278
99. Weiss LM and Chang KL (1996) Association of the Epstein-Barr virus with hematolymphoid neoplasia. Advances in Anatomic Pathology 3 1-15
100. Weiss LM, Lapatgui JR, Sun LH, Kamel OW, Chae HK and Glackin C (1995) Absence of the t(2;5) in Hodgkin's disease. Blood 85 2845-2847
101. Wellmann A, Otsuki T, Vogelbruch M, Clark HM, Jaffe ES and Raffeld M (1995) Analysis of r(2;5)(p23;q35) translocation by reverse trascriptase-polymerase chain reaction in CD30+ anaplastic large cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease. Blood 86 2321-2328
102. Xerri L, Pare P, Hassoun J and Birnbaum D (1996) Molecular analysis of the NPM-ALK rearrangement in Hodgkin's disease. Journal of Pathology 178 128-132
103. Zukerberg LR, Collins AB, Ferry JA and Harris NL (1991) Co-expression of CD15 and CD20 by Reed-Sternberg cells in Hodgkin's disease. American Journal of Pathology 139 475-483